All patients | ‘Early BSC decision’ group | ‘Further investigations’ group | |
---|---|---|---|
Age, years, mean (SD) | 79.1 (10.1) | 79.7 (11.1) | 78.1 (8.51) |
WHO performance status, n (%): 0 1 2 3 4 | 0 (0) 6 (8) 9 (12) 47 (61) 15 (19) | 0 (0) 2 (4) 4 (9) 27 (59) 13 (28) | 0 (0) 4 (13) 5 (16) 20 (65) 2 (6) |
Clinical frailty score, n (%): 1 2 3 4 5 6 7 8 9 | 0 (0) 0 (0) 0 (0) 1 (1) 5 (6) 31 (40) 20 (26) 2 (3) 1 (1) | 0 (0) 0 (0) 0 (0) 1 (2) 2 (4) 21 (46) 11 (24) 2 (4) 1 (2) | 0 (0) 0 (0) 0 (0) 0 (0) 3 (10) 10 (32) 9 (29) 0 (0) 0 (0) |
score not available | 17 (22) | 8 (17) | 9 (29) |
TNM stage, 8th edition, n (%): I II III IV | 5 (6) 3 (4) 17 (22) 52 (68) | 1 (2) 2 (4) 12 (26) 31 (67) | 4 (13) 1 (3) 5 (16) 21 (68) |
Initial decision maker, n (%): | |||
consultant | 55 (71) | 33 (72) | 32 (71) |
senior fellow | 17 (21) | 9 (19) | 8 (26) |
registrar | 5 (6) | 4 (9) | 1 (3) |
Seen by lung CNS, n (%) | 69 (90) | 39 (85) | 30 (97) |
Seen by specialist palliative care, n (%) | 42 (55) | 22 (48) | 20 (65) |
CNS = cancer nurse specialist; SD = standard deviation; TNM = tumour, node and metastasis; WHO = World Health Organization.